Hos patienter med Crohns sygdom, blev der identificeret anti- adalimumab- antistoffer hos 7/ 269 individer (2, 6%) behandlet med adalimumab.
In patients with Crohn’ s disease, anti-adalimumab antibodies were identified in 7/ 269 subjects (2.6%) treated with adalimumab.